Call (415) 636-9700 Phone Mon–Fri 8a–8p · Sat 9a–5p

Why Severe Anxiety Can Feel Resistant Before It Starts Improving

Anxiety Treatment · Hayward, CA

If you clicked this because you are still anxious after starting treatment, the first thing to know is this: anxiety often improves through training, not instant relief. Medication may lower the intensity. Therapy may give you tools. But the brain usually does not forget fear just because treatment has started.

If your nervous system has spent months or years learning that certain situations, sensations, memories, or uncertainties are dangerous, it may take repeated experience to teach it something different.[1] Anxiety is not magically shooed away by medication. For many people, it has to be retrained.

Anxiety improves through repetition

Anxiety is often a learning problem as much as a symptom problem. The brain learns, “This is dangerous.” Then avoidance confirms the lesson. You avoid the place, cancel the plan, leave the room, check again, ask for reassurance, or stay away from the sensation that scares you. Anxiety drops for the moment, so the brain concludes, “Escaping kept me safe.” That is how anxiety survives.

Exposure-based therapy works by interrupting that loop.[2] The goal is not to throw yourself into terror. The goal is to approach fear in manageable steps and stay long enough for the brain to learn: this is uncomfortable, but I can handle it. For panic, that may mean learning that a racing heart is not an emergency. For social anxiety, it may mean letting yourself be seen without escaping. For generalized anxiety, it may mean practicing uncertainty without trying to mentally solve every possible outcome.

Progress may still feel anxious at first. That does not automatically mean the treatment is failing. Sometimes it means your brain is in the middle of learning.

Why you may still feel anxious during treatment

Feeling worse for a stretch can be part of the work.

Discomfort early in treatment does not automatically mean it is failing. Three common reasons the anxiety can linger — or even spike — before it eases.
1
Early activationMany anxiety medications, especially SSRIs and SNRIs, take weeks to show clearer benefit — and can feel activating before they help. A slow start is not the same as no response.
2
Exposure can feel worse before betterApproaching fear in manageable steps is uncomfortable on purpose. Staying long enough teaches the brain “I can handle this” — but the early sessions can feel harder, not easier.
3
Give it an adequate trialThe brain retrains through repetition. Judging progress only by “Am I calm yet?” too soon can hide real movement that is already underway.
Slow progress is different from no progressexxceedwellness.com

Medication may lower the volume, not erase the pattern

Medication can be helpful, especially when anxiety is so intense that you cannot sleep, function, or participate in therapy. But many anxiety medications, especially SSRIs and SNRIs, take weeks to show clearer benefit.[1] Even when they help, they may reduce the volume of anxiety without fully changing the avoidance pattern that keeps anxiety alive.

That is why tracking progress only by asking “Am I calm yet?” can be misleading. Better questions are:

  • Am I avoiding less?
  • Am I recovering faster after triggers?
  • Am I able to stay in situations a little longer?
  • Am I using fewer safety behaviors?
  • Am I doing things I could not do last month?

Those are signs that treatment may be working, even if anxiety has not disappeared yet.

Bring this to your provider

Did treatment get a real trial — and when to reassess.

Track progress by what you can do, not only by how calm you feel. These are signs a plan is working — and the points worth rechecking if it isn’t.
Signs of a real trial / real progress
  • Avoiding less than you were last month.
  • Recovering faster after a trigger sets you off.
  • Staying in situations longer instead of leaving early.
  • Using fewer safety behaviors — checking, reassurance, escape.
  • Medication given weeks, not days, to show its clearer benefit.
When to reassess the plan
  • Anxiety stays severe — recheck the diagnosis; panic, social, GAD, OCD, PTSD, ADHD, thyroid, sleep, and depression can overlap.
  • Therapy lacks enough exposure, or avoidance still runs daily life.
  • Depression is tangled in — if it’s treatment-resistant, ask about the depression-side options.
Save · review before your appointmentexxceedwellness.com

When to recheck the plan

Slow progress is different from no progress. If anxiety remains severe, your provider may need to recheck the diagnosis and treatment plan.[3] Panic disorder, social anxiety, generalized anxiety, OCD, PTSD, ADHD, substance-related anxiety, sleep problems, thyroid issues, and depression can overlap. If the wrong target is being treated, improvement may be limited.

A recheck may also look at whether therapy includes enough exposure, whether medication had a fair trial, whether avoidance is still controlling daily life, and whether depression is part of the picture.[3]

If anxiety is tangled with treatment-resistant depression, treatments like TMS or SPRAVATO/esketamine nasal spray may come up for the depression side of care. SPRAVATO is not a general anxiety treatment.[4] And because intense internal experiences can sometimes increase panic in vulnerable patients, any treatment that may increase neuroplasticity should happen with careful preparation, monitoring, and the right therapeutic support. The goal is to help the brain learn safety, not accidentally rehearse fear.

The takeaway

Severe anxiety can feel treatment-resistant because progress is often slow, uneven, and uncomfortable. But discomfort during treatment does not always mean treatment is failing. Sometimes it means the brain is still learning. The question is not only, “Am I calm yet?” The better question is: am I slowly becoming less controlled by fear?

Still anxious during treatment? · Exxceed Wellness

Let’s find out if it’s working — or needs a recheck.

Slow progress is different from no progress. We’ll look at whether your plan got a real trial, whether the right target is being treated, and what comes next — so you’re measuring recovery by becoming less controlled by fear, not just “Am I calm yet?”

Book a consultation

Nefretiri Abat, JD, PMHNP-BC · Hayward, CAexxceedwellness.com

References

  1. National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline CG113. nice.org.uk/guidance/cg113.
  2. Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014;58:10-23. PMID: 24864005 · doi:10.1016/j.brat.2014.04.006.
  3. Domschke K, Seuling PD, Schiele MA, et al. The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline. World Psychiatry. 2024;23(1):113-123. PMID: 38214637 · doi:10.1002/wps.21177.
  4. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray — Highlights of Prescribing Information. Revised 2025. accessdata.fda.gov (211243s019lbl.pdf). (J&J standalone monotherapy approval for treatment-resistant depression announced January 21, 2025.)

Comments are closed